Axel Semjonow

National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers

Catharine M. Sturgeon, Michael J. Duffy, Ulf‐Håkan Stenman et al. · Clinical Chemistry · 2008 · 1.1K citations

Phase III Postoperative Adjuvant Radiotherapy After Radical Prostatectomy Compared With Radical Prostatectomy Alone in pT3 Prostate Cancer With Postoperative Undetectable Prostate-Specific Antigen: ARO 96-02/AUO AP 09/95

Thomas Wiegel, Dirk Bottke, Ursula Steiner et al. · Journal of Clinical Oncology · 2009 · 815 citations

Adjuvant Radiotherapy Versus Wait-and-See After Radical Prostatectomy: 10-year Follow-up of the ARO 96–02/AUO AP 09/95 Trial

Thomas Wiegel, Detlef Bartkowiak, Dirk Bottke et al. · European Urology · 2014 · 444 citations

Urology, Surgical Oncology, Radiation Medicine +9

Multiple recognition assay reveals prostasomes as promising plasma biomarkers for prostate cancer

Gholamreza Tavoosidana, Gunnar Ronquist, Spyros Darmanis et al. · Proceedings of the National Academy of Sciences · 2011 · 242 citations

Comparison of 10 serum bone turnover markers in prostate carcinoma patients with bone metastatic spread: Diagnostic and prognostic implications

Klaus Jung, Michael Lein, Carsten Stephan et al. · International Journal of Cancer · 2004 · 225 citations